ASHLEA LAMBERTH: Open Payments
NPI 1700820388 · PORTLAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 115 payments from 22 companies in 2025. Trend: 2023 $2,049 · 2024 $2,068 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $288 |
| Novo Nordisk Inc | 13 | $276 |
| ABBVIE INC. | 22 | $256 |
| Lilly USA, LLC | 14 | $189 |
| PFIZER INC. | 8 | $186 |
| Corcept Therapeutics | 11 | $167 |
| Axsome Therapeutics, Inc. | 5 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: XIFAXAN, Korlym, NURTEC ODT, Ozempic, UBRELVY, Auvelity, CAPLYTA, QULIPTA.
Industry payments across TN — which companies pay providers there.
